Methylphenidate Hydrochloride Tablet, Chewable
FDA Label NDC 64980-223

39 label sections · Submitted to the FDA by Rising Pharma Holdings, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rising Pharma Holdings, Inc. for the product Methylphenidate Hydrochloride (NDC 64980-223). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, 1 indications and usage, 2.1 pretreatment screening, 2.2 recommended dosage and administration information, 2.3 dosage reduction and discontinuation, 3 dosage forms and strengths, 4 contraindications, 5.1 abuse, misuse, and addiction, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

5.11 Risk Of Choking

Methylphenidate Hydrochloride Chewable Tablets may swell and block the throat or esophagus which can cause the patient to choke. Avoid use of Methylphenidate Hydrochloride Chewable Tablets in patients who have difficulty swallowing. Administer with at least 8 ounces of fluid [see Dosage and Administration (2.2)]. Discontinue Methylphenidate Hydrochloride Chewable Tablets and seek immediate medical attention if chest pain, vomiting, difficulty in swallowing, or difficulty in breathing occur after administration.

8.6 Renal Impairment

Methylphenidate hydrochloride has not been studied in patients with renal impairment.

Principal Display Panel - 10 Mg

NDC 64980-223-01
Methylphenidate Hydrochloride Chewable Tablets
10 mg
PHARMACIST: Please Dispense with Medication Guide provided with product.
100 Tablets
Rx only

10mg-label (10mg Label)

10mg-label (10mg Label)

* Please review the disclaimer below.